These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preliminary observations on topiramate in pediatric epilepsies. Glauser TA Epilepsia; 1997; 38 Suppl 1():S37-41. PubMed ID: 9092958 [TBL] [Abstract][Full Text] [Related]
3. Topiramate: a review of its use in childhood epilepsy. Ormrod D; McClellan K Paediatr Drugs; 2001; 3(4):293-319. PubMed ID: 11354701 [TBL] [Abstract][Full Text] [Related]
4. Preliminary open-label experience with topiramate in primary generalized seizures. Biton V Epilepsia; 1997; 38 Suppl 1():S42-4. PubMed ID: 9092959 [TBL] [Abstract][Full Text] [Related]
5. Topiramate use in pediatric patients. Glauser TA Can J Neurol Sci; 1998 Aug; 25(3):S8-12. PubMed ID: 9706734 [TBL] [Abstract][Full Text] [Related]
7. Use of topiramate in childhood generalized seizure disorders. Wheless JW J Child Neurol; 2000; 15 Suppl 1():S7-13. PubMed ID: 11218056 [TBL] [Abstract][Full Text] [Related]
8. Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group. Glauser TA; Levisohn PM; Ritter F; Sachdeo RC Epilepsia; 2000; 41(S1):86-90. PubMed ID: 10768308 [TBL] [Abstract][Full Text] [Related]
9. Topiramate: a new antiepileptic drug. Privitera MD Ann Pharmacother; 1997 Oct; 31(10):1164-73. PubMed ID: 9337443 [TBL] [Abstract][Full Text] [Related]
10. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Langtry HD; Gillis JC; Davis R Drugs; 1997 Nov; 54(5):752-73. PubMed ID: 9360061 [TBL] [Abstract][Full Text] [Related]
11. Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study. Coppola G; Caliendo G; Veggiotti P; Romeo A; Tortorella G; De Marco P; Pascotto A Epilepsy Res; 2002 Sep; 51(1-2):147-53. PubMed ID: 12350390 [TBL] [Abstract][Full Text] [Related]
12. Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy. Ben-Menachem E; Sander JW; Stefan H; Schwalen S; Schäuble B Clin Ther; 2008 Jul; 30(7):1180-95. PubMed ID: 18691980 [TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience. Ben-Menachem E Epilepsia; 1997; 38 Suppl 1():S28-30. PubMed ID: 9092955 [TBL] [Abstract][Full Text] [Related]
14. Topiramate: a review of its use in the treatment of epilepsy. Lyseng-Williamson KA; Yang LP Drugs; 2007; 67(15):2231-56. PubMed ID: 17927286 [TBL] [Abstract][Full Text] [Related]
16. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Sachdeo RC; Glauser TA; Ritter F; Reife R; Lim P; Pledger G Neurology; 1999 Jun; 52(9):1882-7. PubMed ID: 10371538 [TBL] [Abstract][Full Text] [Related]
18. A pooled analysis of adjunctive topiramate in refractory partial epilepsy. Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387 [TBL] [Abstract][Full Text] [Related]
19. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group. Abou-Khalil B Epilepsia; 2000; 41(S1):72-6. PubMed ID: 10768305 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Topiramate YP Study Group. Ritter F; Glauser TA; Elterman RD; Wyllie E Epilepsia; 2000; 41(S1):82-5. PubMed ID: 10768307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]